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Poor Sleep and Emotion Dysregulation Mediate the Association between Depressive and 
Premenstrual Symptoms in Young Adult Women: Supplemental File 
 
In order to assess the impact of imputed values on the associations between depressive symptoms, 
sleep quality, dysregulated emotions and pre-menstrual symptoms, analyses were rerun including 
only participants who had no missing data (n = 248). Table S1 shows demographic information for 
included participants. Table S2 displays correlation coefficients for pre-menstrual symptoms, 
depressive symptoms, sleep quality and emotion dysregulation. Figure S1 shows the primary 
mediation analyses with separate models assessing sleep and emotion dysregulation as mediators of 
the association between depressive and pre-menstrual symptoms. Finally, Figures S2a-c replicate the 
exploratory analyses conducted in the main paper. 
 
In order to account for the co-measurement of sleep disruption and depression different across 
scales, scale totals were also calculated without the inclusion of items addressing sleep disturbance 
(MDQ and CESD) and depression (MDQ). Table S3 shows the revised descriptive statistics and 
correlation coefficients for each scale. Figure S3 shows the primary mediation analyses conducted 
using scales with items removed, and Figures S4a-c replicate the exploratory analyses found in the 
main paper.   
  
Table S1. Demographic information for participants with no missing values (n = 248). 
 Mean (SD) / % (n) Median (IQR) 
Age 20.73 (1.80) 20.00 (3.00) 
Race   
White 35.1 (87) N/A 
African-American 13.3 (33) N/A 
Asian 29.0 (72) N/A 
Mixed Race 5.6 (14) N/A 
Other 8.1 (20) N/A 
Prefer not to specify 6.9 (17) N/A 
Ethnicity   
Non-Hispanic 50.8 (126) N/A 
Hispanic 41.9 (104) N/A 
Mixed 2.0 (5) N/A 
Other 2.4 (6) N/A 
Prefer not to specify 2.8 (7) N/A 
Menstrual Cycle Regularity   
Usually or always irregular 18.1 (45) N/A 
Somewhat regular 46.4 (115) N/A 
Always regular 35.1 (87) N/A 
Unknown/Prefer not to answer 0.4 (1) N/A 
Moos Menstrual Distress Questionnaire   
Total 62.33 (20.19) 58.00 (22.00) 
Pain 13.55 (4.06) 13.50 (7.00) 
Concentration 11.94 (4.99) 10.00 (6.00) 
Behavioral Change 10.29 (3.74) 10.00 (6.00) 
Automatic Reactions 5.65 (2.45) 5.00 (2.00) 
Water Retention 6.13 (2.33) 5.00 (3.00) 
Negative Affect 15.73 (5.89) 15.00 (9.00) 
Arousal 8.49 (3.54) 7.00 (6.00) 
Control 7.54 (3.16) 6.00 (1.00) 
Center for Epidemiologic Studies Depression Scale Total 
(clinical cut off: 16 or above) 
17.49 (11.24) 16.00 (16.00) 
Difficulties in Emotion Regulation Scale Total (range 36-180) 83.77 (23.31) 83.50 (35.00) 
Pittsburgh Sleep Quality Index Total (scores >5 indicate poor 
sleep quality) 
6.34 (3.00) 6.00 (4.00) 
 
  
Table S2: Correlation coefficients between study variables (n = 428).  
 CESD PSQI DERS 
MDQ  .56* .44* .53* 
CESD   .45* .75* 
PSQI   .35* 
MDQ: Menstrual Distress Questionnaire; CESD: Center for Epidemiologic Studies Depression Scale; 
PSQI: Pittsburgh Sleep Quality Index; DERS: Difficulty in Emotion Regulation Scale.  *p < .001. 
Figure S1. Direct and indirect pathways for primary mediation analyses for participants with no missing data (n = 248). 
 
 
 
 
 
 
 
 
 
  
Direct Effect (c): b = 1.01, se = .09, p < .0001, 95% CI [.82, 1.20] 
Mediated Direct Effect (c’): b = .82, se = .10, p < .0001, 95% CI [.62, 1.02] 
Indirect Effect (ab): b = .19, se = .06, 95% CI [.07, .32]   
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Direct Effect (c): b = 1.01, se = .09, p < .0001, 95% CI [.82, 1.20] 
Mediated Direct Effect (c’): b = .67, se = .14, p < .0001, 95% CI [.40, .95] 
Indirect Effect (ab): b = .33, se = .13, 95% CI [.08, .60] 
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Figure S2a: Direct and indirect pathways for exploratory mediation analyses (n = 248): Pre-Menstrual Pain.  
Dashed line indicates non-significant pathway. 
 
 
  
  
Direct Effect (c): b = .12, se = .02, p < .0001, 95% CI [.07, .16] 
Mediated Direct Effect (c’): b = .07, se = .02, p = .002, 95% CI [.03,.12] 
Indirect Effect (ab): b = .04, se = .01, 95% CI [.02, .07]   
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Direct Effect (c): b = .12, se = .02, p < .0001, 95% CI [.07, .16] 
Mediated Direct Effect (c’): b = .08, se = .03, p = .009, 95% CI [.02, .15] 
Indirect Effect (ab): b = .03, se = .03, 95% CI [-.02, .08] 
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Figure S2b: Direct and indirect pathways for exploratory mediation analyses (n = 248): Pre-Menstrual Concentration.  
 
 
  
Direct Effect (c): b = .22, se = .02, p < .0001, 95% CI [.17, .27] 
Mediated Direct Effect (c’): b = .17, se = .02, p < .0001, 95% CI [.12, .22] 
Indirect Effect (ab): b = .05, se = .02, 95% CI [.02, .09]   
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Direct Effect (c): b = .22, se = .02, p < .0001, 95% CI [.17, .27] 
Mediated Direct Effect (c’): b = .14, se = .04, p = .0002, 95% CI [.07, .21] 
Indirect Effect (ab): b = .08, se = .03, 95% CI [.02, .15] 
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Figure S2c: Direct and indirect pathways for exploratory mediation analyses (n = 248): Pre-Menstrual Negative Affect. 
 
  
Direct Effect (c): b = .29, se = .03, p < .0001, 95% CI [.23, .34] 
Mediated Direct Effect (c’): b = .25, se = .03, p < .0001, 95% CI [.19,.31] 
Indirect Effect (ab): b = .04, se = .02, 95% CI [.01, .07]   
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Direct Effect (c): b = .29, se = .03, p < .0001, 95% CI [.23, .34] 
Mediated Direct Effect (c’): b = .18, se = .04, p < .0001, 95% CI [.10, .26] 
Indirect Effect (ab): b = .11, se = .04, 95% CI [.04, .17] 
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Table S3: Descriptive values and correlation coefficients for scales with overlapping items removed 
(n = 265).  
 
 M (SD) Median (IQR) CESD PSQI DERS 
MDQ Total (no sleep or 
depression items) 
57.97 (18.95) 54.00 (22.00) .55* .45* .53* 
CESD (no sleep item) 16.75 (10.65) 16.00 (16.00)  .44* .74* 
PSQI 6.36 (3.05) 6.00 (4.00)   .34* 
DERS 83.93 (23.35) 84.00 (35.00)    
MDQ: Menstrual Distress Questionnaire; CESD: Center for Epidemiologic Studies Depression Scale; 
PSQI: Pittsburgh Sleep Quality Index; DERS: Difficulty in Emotion Regulation Scale.  *p < .001.
Figure S3. Direct and indirect pathways for primary mediation analyses, overlapping scale items removed (n = 265). 
 
 
 
 
 
 
 
 
 
  
Direct Effect (c): b = .98, se = .09, p < .0001, 95% CI [.80, 1.16] 
Mediated Direct Effect (c’): b = .78, se = .10, p < .0001, 95% CI [.58, .97] 
Indirect Effect (ab): b = .20. se = .06, 95% CI [.09, .33]   
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Direct Effect (c): b = .98, se = .09, p < .0001, 95% CI [.80, 1.16] 
Mediated Direct Effect (c’): b = .64, se = .13, p < .0001, 95% CI [.38, .90] 
Indirect Effect (ab): b = .34, se = .11, 95% CI [.11, .58] 
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Figure S4a: Direct and indirect pathways for exploratory mediation analyses with overlapping items removed (n = 265): Pre-Menstrual Pain.  
Dashed line indicates non-significant pathway. 
 
 
  
  
Direct Effect (c): b = .12, se = .02, p < .0001, 95% CI [.08, .17] 
Mediated Direct Effect (c’): b = .08, se = .02, p = .002, 95% CI [.03,.12] 
Indirect Effect (ab): b = .05. se = .01, 95% CI [.03, .08]   
Depression 
Emotion Dysregulation 
Pain 
Direct Effect (c): b = .12, se = .02, p < .0001, 95% CI [.08, .17] 
Mediated Direct Effect (c’): b = .09, se = .03, p = .007, 95% CI [.03, .16] 
Indirect Effect (ab): b = .03, se = .03, 95% CI [-.02, .08] 
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Figure S4b: Direct and indirect pathways for exploratory mediation analyses with overlapping items removed (n = 265): Pre-Menstrual Concentration.  
 
 
  
Direct Effect (c): b = .23, se = .03, p < .0001, 95% CI [.18, .28] 
Mediated Direct Effect (c’): b = .17, se = .03, p < .0001, 95% CI [.12,.23] 
Indirect Effect (ab): b = .06. se = .02, 95% CI [.03, .10]   
Depression 
Emotion Dysregulation 
Concentration 
Direct Effect (c): b = .23, se = .03, p < .0001, 95% CI [.18, .28] 
Mediated Direct Effect (c’): b = .14, se = .03, p = .0001, 95% CI [.07, .21] 
Indirect Effect (ab): b = .09, se = .03, 95% CI [.03, .16] 
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Figure S4c: Direct and indirect pathways for exploratory mediation analyses with overlapping items removed (n = 265): Pre-Menstrual Negative Affect. 
 
 
Direct Effect (c): b = .24, se = .03, p < .0001, 95% CI [.19, .29] 
Mediated Direct Effect (c’): b = .20, se = .03, p < .0001, 95% CI [.15,.26] 
Indirect Effect (ab): b = .04. se = .01, 95% CI [.01, .07]   
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Direct Effect (c): b = .24, se = .03, p < .0001, 95% CI [.19, .29] 
Mediated Direct Effect (c’): b = .13, se = .04, p = .0005, 95% CI [.06, .21] 
Indirect Effect (ab): b = .11, se = .03, 95% CI [.05, .17] 
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